Live Cell Imaging is a technique to study live cells with the help of images obtained with imaging systems such as microscopes and high content screening systems. Over the past few years, the adoption of high content screening techniques in drug discovery and cell biology has been continuously rising and so is growing the live cell imaging market.As a result, live cell imaging is pervasively gaining a considerable prominence, and its market is garnering colossal accruals. Moreover, the factors such as the increasing prevalence of chronic diseases and growing government funding in cell-based research are escalating the market on the global heights.
Acknowledging the exponential accruals, the market is witnessing currently, Market Research Future (MRFR), in its recently published study report, asserts that the global Live Cell Imaging Market Share will register approximately 9 % CAGR between 2018 -2023, garnering impressive growth by 2023.Additional factors driving the market growth include the various applications of live cell imaging in the biotech and pharmaceutical industry and the rising prevalence of cancer worldwide. Furthermore, increasing approvals from regulatory bodies and spreading awareness foster the market growth.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6075
Global Live Cell Imaging Market- Competitive Analysis:
The competitive market of live cell imaging appears fragmented owing to the many large and small players along with the new entrants churning the competition. Due to the high growth potential and demand in the market; players also plan to increase production of the products used in the cell culture.
Some of the fervent players leading the global live cell imaging market include Leica Microsystems (Germany), Carl Zeiss AG (Germany), Olympus Corporation (Japan), Nikon Corporation (Japan), Sigma-Aldrich Corporation (U.S.), Molecular Devices, LCC (U.S.), GE Healthcare (U.K.), PerkinElmer, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), BioTek Instruments (U.S.), and Thermo Fisher Scientific, Inc. (U.S.).
Global Live Cell Imaging Market- Segments:
MRFR has segmented its analysis into five key dynamics for enhanced understanding.
- By Products: Equipment, Consumables, and Software
- By Technology: Fluorescence Resonance Energy Transfer, Fluorescence Recovery After Photobleaching, High-Content Analysis, Ratiometric Imaging, Fluorescence in Situ Hybridization, Total Internal Reflection Fluorescence Microscopy, and Multiphoton Excitation Microscopy among other Technologies.
- By Application: Cell Biology, Stem Cells, Developmental Biology, and Drug Discovery among others.
- By End-user: Pharmaceutical Companies, Biotechnology Companies, Hospitals, and Diagnostic Laboratories among others.
- By Regions: Europe, North America, APAC and Rest-of-the-World.
Global Live Cell Imaging Market- Regional Analysis:
The North American region dominates the global live cell imaging market with substantial investments made into RD activities in the biotech and pharmaceutical sectors. Furthermore, factors such as the existing well-established healthcare system, the increasing prevalence of cancer cases, and technological advancements drive the market growth in the region.
Also, high capitalization in imaging systems as well as intensive research and development to improve the imaging quality and data functionality foster the market growth. Strong economic conditions in the region fuel the market growth, allowing funding required for research and development. Moreover, the presence of giant players is impacting the market growth in the region, positively.
The European region heading with the increased focus on research and development, especially in the biotechnology sector, accounts for another lucrative market for live cell imaging. Factors such as the government funding support for RD expenditure and rising prevalence chronic diseases are expected to drive the European live cell imaging market. Also, the presence of some of the notable players such as Leica Microsystems, Carl Zeiss AG, and GE Healthcare facilitates the market growth in the region.
The Asia Pacific live cell imaging market is rapidly emerging as a promising market. The increasing number of research labs define the market landscape in the region. Also, rapidly improving economic conditions in the region alongside the growing cancer research activities and developing healthcare technology provide impetus to market growth in the region.
Japan among other APAC countries accounts for the largest market for live cell imaging due to the increase in the prevalence of cancer and demand for live cell imaging techniques. Whereas, in China, factors such as rising geriatric population with chronic diseases and the availability of low-cost diagnostic and treatment options drive the market growth.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/live-cell-imaging-market-6075
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future
+1 646 845 9312
Email: [email protected]